share_log

和鉑醫藥-B：翌日披露報表

HBM HOLDINGS-B: Next Day Disclosure Return

Hong Kong Stock Exchange ·  Apr 30 18:59
Summary by Futu AI
和鉑醫藥-B（和铂医药-B）於2024年4月30日提交了翌日披露報表，披露其已發行股本變動。報告指出，公司於2023年12月19日及12月20日購回並註銷了共1,750,000股普通股，佔其發行前已發行股份的0.23%。購回後，和鉑醫藥-B的結存股份數目為768,490,410股。公司確認，相關股份的購回已獲董事會批准，並符合香港聯合交易所有限公司證券上市規則的要求，包括收取全部款項、履行上市先決條件、存檔所有必要文件，並已完成所有法律規定的遵行。
和鉑醫藥-B（和铂医药-B）於2024年4月30日提交了翌日披露報表，披露其已發行股本變動。報告指出，公司於2023年12月19日及12月20日購回並註銷了共1,750,000股普通股，佔其發行前已發行股份的0.23%。購回後，和鉑醫藥-B的結存股份數目為768,490,410股。公司確認，相關股份的購回已獲董事會批准，並符合香港聯合交易所有限公司證券上市規則的要求，包括收取全部款項、履行上市先決條件、存檔所有必要文件，並已完成所有法律規定的遵行。
AND PLATINUM PHARMACEUTICALS -B (AND PLATINUM PHARMACEUTICALS -B) FILED A NEXT DAY DISCLOSURE REPORT ON APRIL 30, 2024 DISCLOSING CHANGES IN ITS ISSUED SHARE CAPITAL. The report noted that the company repurchased and wrote down a total of 1,750,000 shares of ordinary shares on December 19 and December 20, 2023, representing 0.23% of the shares issued prior to its issuance. After the repurchase, the number of outstanding shares of Platinum Pharmaceutical-B is 768,490,410 shares. The Company confirms that the repurchase of the relevant shares has been approved by the Board of Directors and complies with the requirements of the Listing Rules of the Stock Exchange of HKEx Limited, including the collection of all monies, the fulfillment of the listing prerequisites, the filing of all necessary documents and the completion of compliance with all legal requirements.
AND PLATINUM PHARMACEUTICALS -B (AND PLATINUM PHARMACEUTICALS -B) FILED A NEXT DAY DISCLOSURE REPORT ON APRIL 30, 2024 DISCLOSING CHANGES IN ITS ISSUED SHARE CAPITAL. The report noted that the company repurchased and wrote down a total of 1,750,000 shares of ordinary shares on December 19 and December 20, 2023, representing 0.23% of the shares issued prior to its issuance. After the repurchase, the number of outstanding shares of Platinum Pharmaceutical-B is 768,490,410 shares. The Company confirms that the repurchase of the relevant shares has been approved by the Board of Directors and complies with the requirements of the Listing Rules of the Stock Exchange of HKEx Limited, including the collection of all monies, the fulfillment of the listing prerequisites, the filing of all necessary documents and the completion of compliance with all legal requirements.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.